1. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2007 update. Circulation 2007; 115(5): 69-171.
2. Allender S, Peto V, Scarborough P, Boxer A, Rayner M. Coronary Heart Disease Statistics. London: British Heart Foundation, 2007.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340(2): 115-126.
4. Festa A, D’Agostino R, Tracy RP, Haffner SM. Insulin resistance atherosclerosis study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002; 51(4): 1131-1137.
5. Walker D, Jason J, Wallace K, Slaughter J, Whatley V, Han A, Nwanyanwu OC, Kazembe PN, Dobbie H, Archibald L, Jarvis WR. Spontaneous cytokine production and its effect on induced production. Clin Diagn Lab Immunol 2002; 9(5): 1049-1056.
6. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in “cachectic” patients with severe chronic heart failure. Br Heart J 1991; 66(5): 356-358.
7. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 1993; 259(5091): 87-91.
8. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor a: a key component of the obesity-diabetes link. Diabetes 1994; 43(11): 1271-1278.
9. Jovinge S, Hamsten A, Tornvall P, Proudler A, Båvenholm P, Ericsson CG, Godsland I, de Faire U, Nilsson J. Evidence for a role of tumor necrosis factor a in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 1998; 47(1): 113-118.
10. Raabe T, Bukrinsky M, Currie RA. Relative contribution of transcription and translation to the induction of tumor necrosis factor-a by lipopolysaccharide. J Biol Chem 1998; 273(2): 974-980.
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94(7): 3195-3199.
12. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, Cambien F. Polymorphisms of the tumour necrosis factor-a gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28(1): 59-66.
13. Padovani JC, Pazin-Filho A, Simões MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000; 100(4): 263-269.
14. Keso T, Perola M, Laippala P, Ilveskoski E, Kunnas TA, Mikkelsson J, Penttilä A, Hurme M, Karhunen PJ. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001; 154(3): 691-697.
15. Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schömig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159(1): 137-144.
16. Bernard V, Pillois X, Dubus I, Benchimol D, Labouyrie JP, Couffinhal T, Coste P, Bonnet J. The –308 G/A tumor necrosis factor-a gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med 2003; 41(4): 511-516.
17. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A, Mastroianno S, De Cosmo S, Fanelli R, Trischitta V. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002; 147(5): 649-654.
18. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined–a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36(3): 959-969.
19. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, Blackwell JM. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182(5): 1259-1264.
20. Antonicelli R, Olivieri F, Cavallone L, Spazzafumo L, Bonafè M, Marchegiani F, Cardelli M, Galeazzi R, Giovagnetti S, Perna GP, Franceschi C. Tumor necrosis factor-a gene –308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis 2005; 16(8): 489-493.
21. Vayssier M, Favatier F, Pinot F, Bachelet M, Polla BS. Tobacco smoke induces coordinate activation of HSF and inhibition of NFk in human monocytes: effects on TNF a release. Biochem Biophys Res Commun 1998; 252(1): 249-256.
22. Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, Lambert D, Visvikis S. Biological variations, genetic polymorphisms and familial resemblance of TNF-a and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet 2005; 13(1): 109-117.
